VillageMD has turned out to be a challenging venture for Walgreens, which invested $5.2 billion in 2021 to take a majority ...

The drugstore chain booked pharmacy sales gains, and its struggling VillageMD clinic business delivered a smaller balance ...

The U.S. healthcare segment reported Q2 revenue of $2.2 billion, a decrease of $23 million, reflecting lower fee-for-service ...

The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth quarter of this year.

Walgreens delivered a better-than-expected fiscal second quarter and smaller loss a month after announcing that it would be ...

Walgreens’ second-quarter report is one of its last financial disclosures before the struggling drugstore chain ends its ...

Adjusted earnings came in at $0.63 per share for the three-month period ended Feb. 28, exceeding analyst expectations of ...

Walgreens Boots Alliance reported quarterly profit that exceeded Wall Street’s expectations, marking a strong performance in ...

Drug store chain reports revenue and adjusted earnings that topped estimates as it prepares to be taken private ...

The drugstore chain booked pharmacy sales gains, and its struggling VillageMD clinic business delivered a smaller balance sheet hit in the recently concluded quarter. Overall, Walgreens said ...

The results include a $4.2 billion charge related to a loss in value of its U.S. retail pharmacy and investment in primary-care clinic chain VillageMD. But Walgreens made $1 billion in profit by ...